Prot #B9991040: A Phase 1b/2 Study to Evaluate Safety and Clinical Activity of Avelumab in Combination with Bempegaldesleukin (NKTR-214) with or without Talazoparib or Enzalutamide in Participants with Locally Advanced or Metastatic Solid Tumors

Project: Research project

Project Details

StatusActive
Effective start/end date2/10/202/10/23

Funding

  • Pfizer Inc. (Prot #B9991040)